NFTRH+; Biotech iShares ETF, Daily & Weekly
First off, I believe we are entering a rising interest rate environment, quite possibly in line with the preferred view of inflationary pressures out ahead. In that regard, I want…
First off, I believe we are entering a rising interest rate environment, quite possibly in line with the preferred view of inflationary pressures out ahead. In that regard, I want…
Me neither. Boston Scientific (BSX) was a very successful NFTRH+ long idea nearly a year ago (w/ updates along the way). Today? Not so much (indeed, I gave it a…
Please reference (and pardon the promotional tone of) the previous post, which updates HUI's current situation. Here is a simple chart from the post showing HUI at the logical pullback…
Even in bull markets the corrections are brutal. That is because this is a relatively small sector subject to relatively large hype. When the gold sector gets sharp pullbacks the…
The most important ISM element is the one that improved the most in September; New Orders. Order Backlog contraction eased as well, to near even. A few notables are highlighted…
It's one NFTRH segment among many, and certainly not the sexiest of them. But it is among the more important ones in my opinion. I don't mean to be cavalier…
US Stock Market: Trend is bullish, but other than the big display in the Semis last week and a bullish looking Tranny, most items remain below the key parameter we…